April 19, 2026 · 4 min read · Whally Team
The raise is not described as generic growth capital. It is mapped into R&D, CE-IVDR and regulatory work, research partnerships, and operations.
That matters because the company is not building a pure software product. Commercial success depends on assay quality, image interpretation, manufacturing readiness, compliance, and measured entry into the Netherlands.
The timeline shown in the deck moves from an MVP app through regulatory milestones and beta rollout toward Q1 2028 shipment and market entry. The website should therefore present Whally as a product company with both technical and regulatory depth.
